SMS Pharmaceuticals Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

SMS Pharmaceuticals Company Profile :

SMS Pharmaceuticals Limited is an Indian company engaged in the business of manufacturing and sale of active pharmaceutical ingredients (APIs) and their intermediates.

Company offers a range of anti-ulcer, anti-fungal, anti-migraine, anti-hypertensive and other API products.

Company also offers a range of erectile dysfunction, anti-cancer, anti-viral and pulmonary arterial hypertension intermediate products.

Company’s plants are located in Telangana and Andhra Pradesh in India.


Sms Pharmaceuticals ResultsBSE Code : 532815
NSE Symbol : SMSPHARMA
ISIN No. : INE812G01025
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of SMS Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of SMS Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of SMS Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of SMS Pharmaceuticals.

SMS Pharmaceuticals Q1 Results 2016-17 :

SMS Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT
Tax
Net Profit
Equity
EPS  –

SMS Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

SMS Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

SMS Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

SMS Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

SMS Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 603.19 603.19
Other Income  3.61  3.60
Total Income  606.80  606.79
Expenditure -514.00  -533.43
Interest -17.10  -17.09
Depreciation -19.43  -19.43
PBT 56.27  56.27
Tax -14.63  -14.63
Net Profit 41.64  41.63
Equity 8.47  8.47
EPS 4.92  4.83

Note : If you like this information about SMS Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.